Amsino International Inc., a US-based medical device manufacturer, acquired the assets of MedXL Inc. and Liebel-Flarsheim Canada Inc. (collectively, "MedXL”) located in Montreal, Québec, Canada.

The transaction was a distressed M&A deal with Amsino being the successful bidder for MedXL, which emerged from CCAA protection following a Sale and Investment Solicitation Process. This acquisition includes substantially all the existing assets and infrastructure at MedXL facilities, such as intellectual property, real estate, manufacturing equipment, and global product registrations in approximately 60 countries.

BLG represented Amsino International with a team led by François Gagnon that included Kevin Mailloux (Financial Services); Neil Hazan and Francis Lussier, Jordan Jaslow, Guillaume Laplante and Cathy Grégoire (Corporate/M&A); Vincent Frenette, Jordan Bouchard and Nathalie Olivier (Financial Services); Joseph Takhmizdjian, Alessandro Cotugno (Tax), Andrew Reid Workman, Line Abecassis and Charlotte Libman (Commercial Real Estate); Manon Gauthier (Health Regulatory), Justine Laurier, Audrey Belhumeur (Labour & Employment); and Denes Rothschild (Investment Canada Act).